It may be possible that NGF stimulate TrkA rather than p75NTR in aggressive cancers with high malignant potential, as results of a study by Sakamoto et al (2001a) showed that patients with NGF+ and p75NTR− had poorer survival in breast cancer. The gene discussed is NGF; the disease is breast carcinoma.